single drug vs double drug in new diabetic adults.
Phase 4
Completed
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/05/052868
- Lead Sponsor
- Dr Sridevi S A (self)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
newly diagnosed type 2 diabetes mellitus with HbA1C more than 6.5 % associated with hypertension, obesity, hyperlipidemia.
Exclusion Criteria
age less than 35 and more than 55 type 1 diabetes mellitus hypertensives, hyperlipidemics renal or hepatic disease pregnancy lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hbA1CTimepoint: 3rd month, 6th month, 12th month
- Secondary Outcome Measures
Name Time Method fasting blood sugar, post prandial blood sugar, lipid profile, BP, waist circumference ratio , urine routine <br/ ><br>QOL(quality of life) indexTimepoint: baseline, 6th month(investigations) <br/ ><br> <br/ ><br>QOL at 6th month and 12th month